HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

GL

Globe Life Inc. (S&P 500)

Financial Services — Insurance - Life

Globe Life Inc., through its subsidiaries, provides various life and supplemental health insurance products to lower middle- and middle-income families in the United States. It operates in three segments: Life Insurance, Supplemental Health Insurance, and Investments. The company offers whole, term, and other life insurance products, as well as life insurance for children; Medicare supplement and limited-benefit supplemental health insurance products, such as accident, cancer, critical illness, heart, intensive care, and other health products; and final expense, accidental death, mortgage protection, and hospital insurance products. It sells its products through direct-to-consumer channels, exclusive independent agents, general agency independent agents, and brokers. The company was formerly known as Torchmark Corporation and changed its name to Globe Life Inc. in August 2019. Globe Life Inc. was founded in 1900 and is headquartered in McKinney, Texas.

None 11 analysts
$165.83
+$0.18 (+0.11%)
Target: $193.91 (16.9%)

Price History

52-Week Range
Sign in to add GL to a watchlist or set price alerts.

Fundamentals

Market Cap$12.74B
P/E Ratio (TTM)11.03
Forward P/E10.04
EPS (TTM)$15.04
Dividend Yield0.80%
Profit Margin19.58%
Revenue Growth8.00%
ROE20.94%
Debt/Equity55.68
Recommendation None
Analyst Target$193.91
Analysts11
Next Earnings Jul 22, 2026 AMC
Indexes S&P 500

Technical Indicators

RSI (14)28.2
Beta0.46
SMA 20$170.35
SMA 40$173.48
52-Week High$191.55
52-Week Low$127.85
50-Day Avg$175.04
200-Day Avg$157.13
Avg Volume540.8K
Volume801.7K

Performance Analysis

BULLISH

GL shows predominantly bullish signals based on its fundamentals and technicals.

~ Trading at 60% of its 52-week range.
+ RSI at 28.2 signals oversold conditions — a bounce may be ahead.
~ Price dropped below the 50-day average but remains above the 200-day — possible short-term weakness.
+ P/E of 11.0 suggests the stock may be undervalued.
~ Modest revenue growth of 8.0% year-over-year.
~ Wall Street consensus is "none" from 11 analysts.
+ Average analyst target of $193.91 implies 16.9% upside.

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Oct 01, 2026 21:01 UTC

Back to Screener Export Report